Shares of technology and consulting firm Take Solutions Ltd have captured significant attention from stock market investors following a remarkable 150% surge in its share price over the last one-year period, as per data from the National Stock Exchange (NSE). This small-cap stock, trading under ₹50, is now in the spotlight not just for its recent gains but also for its strategic pivot towards the healthcare sector.
Impressive Stock Performance Metrics
An analysis of the NSE data reveals a multi-faceted performance story for Take Solutions. While the stock has delivered stellar returns of over 69% to investors in the last three years and a standout 150% gain in the past year, the five-year view shows a decline of 29.62%. However, recent momentum is strong, with the share price climbing 24.23% in the last month and gaining 3.54% over the previous five trading sessions.
In the latest session, Take Solutions shares closed at ₹40.40, marking a 1.15% increase from the previous close of ₹39.94. The stock reached its 52-week high of ₹41.20 on 31 December 2025, a stark contrast to its 52-week low of ₹6.51. As of the market close on 1 January 2026, the company's market capitalisation stood at ₹597.65 crore.
Strategic Shift: Building an AI Healthcare Future
The company's future plans are adding a new dimension to its investment narrative. In an exchange filing dated 23 December 2025, Take Solutions announced its intention to develop an advanced AI-driven diagnostic and preventive care platform. This initiative is part of a long-term strategy to establish a significant presence in the healthcare domain.
The company stated that this platform aligns with its vision to support India's transition from treatment-focused systems to a model emphasizing AI-led early detection, predictive diagnostics, and preventive care. This strategic move could open new growth avenues for the firm, which traditionally provides technology and consulting services in life sciences and supply chain management, aiding clients with clinical research, compliance, and regulatory affairs.
Recent Leadership Changes
The period of high growth and strategic announcement was also marked by significant changes in the company's leadership. On 31 December 2025, Vedamirtham Venkatesan, the Whole-time Director and Chief Financial Officer (CFO), resigned from his positions with immediate effect. In his resignation letter to the board, he cited pre-occupations and other personal commitments.
On the same day, company director Cecily Dheepa also stepped down, giving similar reasons for her departure. The resignations of both key personnel were effective from 31 December 2025, introducing an element of management transition during a pivotal phase for the company.
Investor Takeaway
Take Solutions presents a compelling case for investors tracking the small-cap segment. The stock's explosive one-year return of 150% and its ambitious foray into the AI-powered healthcare space are key highlights. However, investors must also consider the longer-term volatility, evidenced by the five-year loss, and the recent top-level management exits. The company's ability to execute its new AI healthcare vision while maintaining its core business strengths will likely be the critical factor determining its trajectory on the stock market in the coming years.
